2026 Edition,cyclic peptide synthesis

The synthesis of cyclic peptides has emerged as a critical area within peptide chemistry, offering unique advantages in terms of stability, bioavailability, and therapeutic potential. A cornerstone of this advanced peptide synthesis is the application of sophisticated ligation technologies. These methods allow for the precise formation of cyclic architectures, moving beyond traditional linear peptide synthesis and opening doors to novel molecular designs. Understanding these ligation technologies for the synthesis of cyclic peptides is paramount for researchers aiming to create complex peptide structures for various applications, from drug discovery to materials science.

One of the most prominent and widely utilized techniques is native chemical ligation (NCL). This powerful approach enables precise cyclic peptide construction, significantly improving their inherent stability and allowing for the creation of intricate macrocyclic architectures. NCL relies on the chemoselective reaction between a peptide with an N-terminal cysteine residue and a peptide thioester. This reaction results in the formation of a native peptide bond, mimicking the natural process of protein ligation. The versatility of NCL has been further expanded through various modifications and extensions, making it a central tool in the synthesis of cyclic peptides. For instance, on-resin intramolecular native chemical ligation (NCL), often assisted by N-ethylcysteine and employing Fmoc/SPPS (Fmoc/Solid Phase Peptide Synthesis), has been developed to efficiently yield cyclic peptides directly on a solid support. This streamlined approach accelerates the synthesis workflow and simplifies purification.

Beyond NCL, a diverse array of different chemoselective ligation technologies used for cyclic peptide synthesis has been developed. These include methods that generate both native and unnatural peptide bonds, offering greater flexibility in designing peptide structures with tailored properties. For example, peptide ligation techniques are being explored that utilize natural- and engineered peptide ligases. Enzymes such as sortase, butelase, peptiligase, or omniligase generally offer excellent chemoselectivity and biocompatibility compared to purely chemical ligation methods. These enzyme-mediated ligation technologies are particularly attractive for their mild reaction conditions and high efficiency.

Furthermore, Omniligase-1-catalyzed ligation represents a powerful tool for both intermolecular and intramolecular ligation, including head-to-tail cyclization. This enzymatic approach has demonstrated significant potential in the efficient synthesis of complex cyclic peptides. The concept of head-to-tail cyclization enhances peptide stability and bioactivity, making it a desirable strategy for therapeutic peptide development.

Another significant advancement in the field is the integration of click chemistry into peptide synthesis. Techniques like tetrazine-alkene ligation, as utilized by LifeTein for peptide-drug conjugation, offer rapid and highly efficient bond formation under mild conditions. Similarly, inter- and intramolecular click reactions using azide or alkyne-containing amino acids or building blocks during peptide synthesis provide alternative routes to constructing cyclic peptide frameworks. These methods are often characterized by high yields and minimal side reactions, contributing to the overall efficiency of cyclic peptide synthesis.

The ability to synthesize cyclic peptides has also been revolutionized by advancements in chemical synthesis and peptide ligation techniques. These methodologies have not only expanded the scope of accessible peptide structures but have also played a crucial role in protein engineering by enabling the precise construction of peptides. Technologies like CLIPS technology (Chemical Linkage of Peptide onto Scaffolds) are proprietary and highly versatile, allowing for the cyclization of linear peptides into various topologies such as head-to-tail, side-chain-to-side-chain, and head-to-side-chain. This versatility in cyclic peptide synthesis allows for the creation of peptides with diverse three-dimensional structures, which can lead to enhanced biological activity and stability.

The exploration of cyclic peptides via ligation methods continues to evolve. Researchers are investigating how ligation methods have facilitated synthetic access to a wide range of naturally occurring cyclic peptides, as well as developing novel cyclic peptide mimics. For instance, the development of structured cyclic peptide mimics by chemical ligation has led to the design of molecules that can directly form cyclic peptides through spontaneous cyclization.

In summary, the field of ligation technologies for the synthesis of cyclic peptides is a dynamic and rapidly advancing area. From the robust and widely adopted native chemical ligation to enzymatic strategies and the innovative application of click chemistry, these methods provide chemists with a powerful toolkit to construct complex and functionally diverse cyclic peptides. The ongoing research and development in this domain are crucial for unlocking the full potential of cyclic peptides in various scientific and therapeutic applications, ultimately contributing to the broader progress in peptide synthesis and its impact on fields that have revolutionised the field of protein engineering.